The transplant recipient journey

The transplant recipient journey is the sequence of clinical, administrative, and personal steps a patient with end-stage organ failure passes through from referral to a transplant center, through evaluation and listing on the national waiting list, the wait for a compatible organ, the transplant operation and recovery, and lifelong post-transplant follow-up. [1][2] In the United States the journey takes place within the framework operated by the Organ Procurement and Transplantation Network (OPTN), which maintains the national waiting list and the computerized system that matches donated organs to candidates. [2][3] This article describes the journey neutrally and in general terms; specifics vary by organ, by transplant program, and by individual medical circumstance, and the article does not provide medical advice.

Referral and evaluation

The journey typically begins when a patient's physician determines that an organ is failing or has failed and refers the patient to a transplant hospital for evaluation. [1] The transplant center then conducts a comprehensive evaluation to determine whether transplantation is an appropriate option and whether the patient is likely to benefit from and tolerate the procedure and the lifelong immunosuppression that follows. [1][4]

Evaluation is multidisciplinary. It generally includes a medical and surgical workup (laboratory testing, imaging, cardiac and other organ-system assessments, blood typing, and tissue typing), a psychosocial assessment (social support, mental health, and the patient's ability to adhere to a complex post-transplant medication regimen), and a financial assessment of insurance coverage and the cost of medications and follow-up care. [4][5] Under OPTN requirements, programs must have written patient-selection criteria and must evaluate candidates through a multidisciplinary team; listing decisions are made jointly by a selection committee that weighs medical and psychosocial factors. [5] The OPTN's General Considerations in Assessment for Transplant Candidacy, approved by the OPTN Board in 2015, frames how programs assess candidacy. [5]

Listing on the national waiting list

If the selection committee accepts the patient, the transplant program adds the patient to the OPTN national waiting list and, per OPTN policy, notifies the patient in writing (organdonor.gov states that the program contacts the patient in writing roughly ten days after listing). [1][6] The waiting list is not a simple first-come, first-served queue; rather, each candidate's record carries the medical and biological information used to rank that candidate whenever a compatible organ becomes available. [3][6] See National transplant waiting list.

Priority on the list is organ-specific. Liver candidates are ranked largely by a medical-urgency score (the MELD or, for children, PELD family of scores); heart candidates are ranked by a multi-tier urgency status system; and kidney candidates accrue priority from waiting time, degree of sensitization, and other factors. [3][7] Sensitization, the presence of preformed anti-HLA antibodies, summarized as the calculated panel-reactive antibody (cPRA), narrows the pool of compatible donors and is given allocation weight to improve access for highly sensitized candidates. [7][8] See Panel-reactive antibody / cPRA and sensitization and OPTN allocation policy.

Waiting and how organs are matched

While the candidate waits, no organ is reserved in advance; instead, each time a deceased-donor organ becomes available the OPTN's computer system generates a "match run," a rank-ordered list of candidates created specifically for that donor and that organ. [3][9] According to UNOS, only medical and logistical factors are used in matching, and personal or social characteristics are not. [9]

The factors that determine whether and how quickly a candidate receives an offer include blood type, body and organ size, immune compatibility (HLA matching and the crossmatch), medical urgency, time spent waiting, and the geographic distance between the donor and transplant hospitals. [3][9] Candidates who are incompatible with a given donor, by blood type, size, or other medical factors, are automatically screened out of that donor's match run. [9] For several organs, distribution is now based on "acuity circles," concentric distance circles measured from the donor hospital that replaced the older donation-service-area and regional boundaries (implemented for liver and intestine in February 2020). [10] Because these factors vary by patient and by organ, waiting times differ widely and cannot be predicted precisely for an individual. [3][6] See The match run.

The organ offer and the transplant operation

When a candidate ranks high enough on a match run, the organ is offered to that candidate's transplant team, which reviews donor information and the candidate's current condition and decides whether to accept the offer. [1][9] If the offer is accepted, the candidate is called to the hospital, final compatibility testing (such as the crossmatch) is completed, and the transplant operation proceeds. [1][9] Because donor organs and recipients must be brought together quickly, solid organs remain viable only for a limited time, candidates are generally advised to be reachable and ready to travel on short notice. [1][6] Surgical technique, length of operation, and hospital stay vary by organ; see the organ-specific articles, including Kidney transplantation, Liver transplantation, Heart transplantation, and Lung transplantation.

Immediate recovery

After the transplant, the recipient is monitored closely in the hospital for organ function, surgical complications, and early signs of rejection or infection. [1] Immunosuppressive (anti-rejection) medications are started, and the care team adjusts them while watching laboratory values. [1] Length of the initial hospital stay and the pace of recovery depend on the organ transplanted and the individual's course. [1]

Lifelong follow-up

Transplantation is a treatment, not a cure, and recipients require lifelong follow-up. [1] The transplanted organ is recognized by the recipient's immune system as foreign, so recipients take immunosuppressive medications, often several drugs, some multiple times a day, for as long as the graft functions, to reduce the risk that the body rejects the organ. [1] Regular laboratory tests and clinic visits become a permanent part of the recipient's life, used to monitor graft function, detect rejection early, and manage side effects. [1]

Because immunosuppression lowers the body's defenses, recipients face an increased long-term risk of infection and of certain cancers, and adherence to the medication regimen is critical to graft survival. [1] The mechanisms of rejection and the drug classes used to prevent it are described in Transplant immunology. Long-term outcomes vary by organ, by donor and recipient characteristics, and over time; program-specific and national outcome data are published by the Scientific Registry of Transplant Recipients (SRTR). [11]

Scale

Transplant activity in the United States is large and growing. In 2024, U.S. transplant centers performed a record 48,149 transplants. [12] At the same time, the national waiting list has consistently exceeded 100,000 candidates, far more than the number of organs available, so many candidates wait months to years and some die or become too sick to transplant while waiting. [13] These figures are point-in-time; the current waiting-list count and annual volume should be confirmed against the primary OPTN/HRSA sources at publication. (Figures as of 2026-06-24.) See The organ donation gap.

See also

• Organ transplantation
• The donation pathway
• OPTN allocation policy
• Panel-reactive antibody / cPRA and sensitization
• Transplant immunology
• Scientific Registry of Transplant Recipients (SRTR)

References

• Health Resources and Services Administration (HRSA) / OrganDonor.gov. "The Organ Transplant Process." https://www.organdonor.gov/learn/process/transplant-process
• OrganDonor.gov. "How Donation Works." https://www.organdonor.gov/learn/process
• OrganDonor.gov. "Matching Donors and Recipients." https://www.organdonor.gov/learn/process/matching
• National Kidney Foundation. "The Kidney Transplant Waitlist." https://www.kidney.org/kidney-topics/kidney-transplant-waitlist
• Organ Procurement and Transplantation Network (OPTN) / HRSA. "General Considerations in Assessment for Transplant Candidacy." https://www.hrsa.gov/optn/professionals/resources/ethical-considerations/general-considerations-in-assessment-for-transplant-candidacy
• OrganDonor.gov. "The Organ Transplant Process" (waiting and notification). https://www.organdonor.gov/learn/process/transplant-process
• United Network for Organ Sharing (UNOS). "How we match organs." https://unos.org/transplant/how-we-match-organs/
• American Journal of Transplantation. "Calculated panel-reactive antibody (cPRA) and sensitization." https://www.amjtransplant.org/
• UNOS. "Is it really a list? What determines how organs are allocated, and the role UNOS technology plays in it." https://unos.org/news/is-it-really-a-list-what-determines-how-organs-are-allocated-and-the-role-unos-technology-plays-in-it/
• UNOS. "System implementation notice: Liver and intestinal organ distribution based on acuity circles implemented Feb. 4." https://unos.org/news/system-implementation-notice-liver-and-intestinal-organ-distribution-based-on-acuity-circles-implemented-feb-4/
• Scientific Registry of Transplant Recipients (SRTR). "Program-Specific Reports." https://www.srtr.org/
• HRSA. "Organ Transplants Exceeded 48,000 in 2024." https://www.hrsa.gov/optn/news-events/news/organ-transplants-exceeded-48000-2024-33-percent-increase-transplants-performed-2023
• OrganDonor.gov. "Organ Donation Statistics." https://www.organdonor.gov/learn/organ-donation-statistics